Charles River Laboratories International, headquartered in Wilmington, Massachusetts, provides products and services to pharmaceutical and biotechnology companies with 20,000 employees. The company offers research models, safety assessment, and manufacturing solutions since its IPO in 2000.
Charles River Laboratories International (CRL) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Charles River Laboratories International's actual EPS was $2.34, beating the estimate of $2.10 per share, resulting in a 11.43% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
